
Datura is a genus of nine species of flowering plants in the Solanaceae (nightshade) family, and it occupies a position in psychoactive culture unlike any other substance: feared, revered, and almost universally regretted by those who have tried it recreationally. The most commonly encountered species -- Datura stramonium (jimsonweed/thorn apple), Datura inoxia, and Datura metel -- grow wild across every inhabited continent, thriving in disturbed soil, roadsides, and empty lots with a weedy indifference to human plans. Every part of the plant is toxic. Every part is psychoactive. And the line between those two properties is, for all practical purposes, nonexistent.
The active compounds are tropane alkaloids -- primarily atropine, scopolamine (hyoscine), and hyoscyamine -- which act as competitive antagonists at muscarinic acetylcholine receptors throughout the central and peripheral nervous system. Blocking acetylcholine at these receptors produces an anticholinergic delirium that is pharmacologically and experientially distinct from anything produced by classical psychedelics, dissociatives, or empathogens. This is not a "trip" in any meaningful sense of the word. Users do not experience visual enhancements or expanded consciousness. They experience a state of toxic psychosis in which hallucinations are indistinguishable from reality, communication with people who are not there feels completely normal, and the memory of everything that happened may be partially or completely absent.
What makes datura genuinely dangerous -- beyond the delirium itself -- is the impossibility of dosing it safely. Alkaloid concentration varies by a factor of 5:1 or more between individual plants, between different parts of the same plant, between seasons, and even between leaves on the same branch. A dose of seeds from one pod that produces mild effects could be lethal from the next pod on the same plant. No preparation method, no "experienced" user, no traditional recipe eliminates this variability. There is no safe dose of datura, because there is no way to know what dose you are taking.
Despite this -- or perhaps because of it -- datura has been used by humans for thousands of years. Hindu traditions consider it sacred to Shiva. Amazonian shamans use Datura and the closely related Brugmansia in initiatory rites. European witches reportedly used tropane alkaloid-containing plants in "flying ointments." Colonial American soldiers were accidentally poisoned by it in 1676 Jamestown. And every year, teenagers and curious experimenters eat datura seeds after reading about it online, producing a steady stream of emergency department visits, horrifying trip reports, and occasional deaths. The experience is so consistently described as nightmarish that datura may be the only psychoactive substance whose user community actively and unanimously discourages its use.
Safety at a Glance
High Risk- The Only Safe Dose Is None
- If someone has already decided to use datura despite this, the following may reduce (but cannot eliminate) the risk o...
- Toxicity: Acute Toxicity: The Anticholinergic Crisis Datura is genuinely toxic in a way that most psychoactive substances are n...
- Dangerous with: 1,4-Butanediol, 2-Aminoindane, 2-FA, 2-FEA (+119 more)
- Overdose risk: Datura Overdose Is a Medical Emergency Unlike most psychoactive substances covered on this site, ...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Duration
oral
How It Feels
There is no gentle way to describe the datura experience, because there is nothing gentle about it. Reading trip reports -- and there are thousands of them, forming one of the most consistently horrifying bodies of experience literature in psychoactive history -- reveals an experience that shares almost nothing with classical psychedelics except the bare fact that perception is altered. But "altered" does not begin to capture it. The datura experience is better described as replaced: consensus reality is overwritten by a toxic confabulation that the user cannot distinguish from waking life, often cannot remember afterward, and almost universally wishes had never happened.
The onset, 30 minutes to two hours after ingesting seeds, tea, or plant material, begins with the peripheral anticholinergic effects. The mouth dries out completely -- a parched, cottony dryness that no amount of water relieves, because the salivary glands have been pharmacologically shut off. Vision blurs as the pupils dilate to their maximum, losing the ability to accommodate. The skin flushes and dries. Heart rate climbs. There is a heavy, sedating body load that many describe as feeling poisoned -- because, in the most literal sense, you are.
Then the delirium arrives, and it is unlike anything in the pharmacological universe. The hallmark of anticholinergic hallucination is its seamless integration with perceived reality. On LSD, you know the walls are not actually breathing. On datura, you have a full conversation with your friend who is sitting right there in the room -- and then you turn around and realize you are alone, and have been alone for hours. You smoke a cigarette down to the filter, flick it away, look down and there is no cigarette, there was never a cigarette, your fingers were pinching air the entire time. This "phantom cigarette" phenomenon is so universal among datura reports that it has become something of a dark inside joke in psychoactive communities, and researchers have speculated it reflects the cholinergic system's role in motor planning and habitual behavior.
The hallucinations are not limited to people and objects. Users report transparent spiders covering surfaces, shadow people in peripheral vision, incomprehensible conversations with deceased relatives, and spatial distortions so severe that navigating a familiar house becomes impossible. Unlike psychedelic visuals, which tend toward geometric abstraction and beauty, anticholinergic hallucinations are mundane, populated with ordinary objects and people -- which is precisely what makes them so disorienting. The brain is not generating novel percepts; it is confabulating ordinary experience from whole cloth, and the systems that would normally detect the error are the very systems that have been disabled.
Amnesia is near-universal. Most users remember the experience in fragments, if at all. Some "wake up" hours later in unfamiliar locations with no memory of how they got there. Reports of being found by police wandering naked, attempting to drive, or engaging in incomprehensible behavior are distressingly common. The experience is not merely unpleasant -- it represents a genuine loss of agency. You are not "tripping." You are delirious, in the clinical sense of the word: a state of acute confusion with fluctuating consciousness, impaired attention, and perceptual disturbance that in any other context would prompt immediate medical intervention.
The duration compounds the misery. Where a difficult LSD trip resolves in 8-12 hours, datura effects routinely persist for 24-48 hours, with some reports describing residual visual disturbances and cognitive fog lasting 3-5 days. Users describe the aftermath as feeling "broken" -- physically drained, cognitively impaired, and psychologically shaken in a way that lingers far longer than the pharmacological effects.
The near-universal verdict from people who have tried it: do not take datura. This is not the "I had a bad trip" ambivalence that follows many psychedelic experiences. It is a flat, unequivocal warning, repeated across decades of trip reports, forum posts, and Reddit threads. The r/Datura subreddit -- a community that ostensibly exists for people interested in this substance -- is predominantly populated by people telling others not to use it.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(25)
- Abnormal heartbeat— Abnormal heartbeat (arrhythmia) is any deviation from the heart's normal rhythm — including beats th...
- Bronchodilation— Bronchodilation is the widening of the bronchial airways in the lungs, reducing resistance to airflo...
- Constipation— A slowing or cessation of bowel movements resulting in difficulty passing stool, commonly caused by ...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Difficulty urinating— Difficulty urinating, also known as urinary retention, is the experience of being unable to easily p...
- Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
- Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
- Frequent urination— Increased urinary frequency beyond normal patterns, caused by diuretic effects or bladder irritation...
- Increased bodily temperature— Increased bodily temperature (hyperthermia) is an elevation of core body temperature above the norma...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Muscle cramp— Muscle cramps are sudden, involuntary, and often painful contractions of muscles that occur as a sid...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Nausea suppression— Nausea suppression is the pharmacological reduction or elimination of nausea and the urge to vomit, ...
- Perception of bodily heaviness— Perception of bodily heaviness is the subjective feeling that one's body has become dramatically hea...
- Photophobia— An abnormal physical intolerance and sensitivity to light that causes discomfort, squinting, or pain...
- Physical fatigue— Physical fatigue is a state of bodily exhaustion characterized by reduced energy, diminished capacit...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Temporary erectile dysfunction— Temporary erectile dysfunction is the substance-induced inability to achieve or sustain a penile ere...
- Vibrating vision— Vibrating vision is the subjective experience of the visual field rapidly oscillating or shaking due...
Tactile(3)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
- Tactile hallucination— Tactile hallucinations are convincing physical sensations experienced without any corresponding exte...
- Tactile suppression— A progressive decrease in the ability to feel physical touch, ranging from mild numbness to complete...
Cognitive & Perceptual Effects
Visual(15)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Brightness alteration— Perceived increase or decrease in environmental brightness beyond actual illumination levels, common...
- Diffraction— The experience of seeing rainbow-like spectrums of color and prismatic halos embedded within bright ...
- Double vision— The visual experience of seeing a single object as two separate, overlapping images, similar to cros...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Object activation— A hallucinatory effect in which stationary objects in the environment appear to spontaneously move, ...
- Object alteration— A visual effect in which objects in the environment appear to warp, stretch, melt, or animate autono...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Shadow people— The perception of dark, humanoid silhouettes lurking in peripheral vision or standing in direct line...
- Unspeakable horrors— A deeply distressing hallucinatory state involving sustained exposure to nightmarish, terrifying, an...
- Visual acuity suppression— Vision becomes blurred, indistinct, and out of focus, as though looking through a smudged lens. Fine...
- Visual haze— A translucent fog or haze overlays the visual field, softening the environment and reducing clarity....
Cognitive(26)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Cognitive dysphoria— A cognitive and emotional state of intense dissatisfaction, discomfort, and malaise encompassing fee...
- Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Delirium— Delirium is a serious and potentially dangerous state of acute mental confusion involving disorienta...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Depersonalization— A detachment from one's own sense of self, body, or mental processes, as if observing oneself from o...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Derealization— A perceptual disturbance in which the external world feels profoundly unreal, dreamlike, or artifici...
- Dream potentiation— Enhanced dream vividness, complexity, and recall, often occurring as REM rebound after discontinuing...
- Emotion suppression— A blunting or flattening of emotional experience in which feelings become muted, distant, or seeming...
- Feelings of impending doom— Feelings of impending doom is the sudden onset of an overwhelming, visceral certainty that something...
- Focus suppression— Focus suppression is a diminished capacity to direct and sustain attention on a chosen target — a ta...
- Language suppression— A diminished ability to formulate, comprehend, or articulate language, ranging from difficulty findi...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Motivation suppression— Motivation suppression is a state of diminished drive and willingness to engage in goal-directed beh...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Sensed presence— Sensed presence is the vivid and often unshakeable feeling that an unseen conscious being — whether ...
- Sleepiness— A progressive onset of drowsiness, heaviness, and the desire to sleep that pulls the individual towa...
- Suggestibility enhancement— Heightened receptivity to external suggestions, ideas, and influence, commonly experienced during ps...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Thought disorganization— Thought disorganization is a cognitive impairment in which the normal capacity for structured, seque...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Auditory(1)
- Auditory hallucination— Auditory hallucination is the perception of sounds that have no external source — hearing music, voi...
Multi-sensory(4)
- Gustatory hallucination— Gustatory hallucinations are phantom taste experiences in which distinct flavors manifest in the mou...
- Memory replays— Memory replays are vivid, multisensory re-experiences of past events that go far beyond normal recal...
- Olfactory hallucination— Olfactory hallucinations (phantosmia) involve the perception of convincing phantom smells — pleasant...
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
Pharmacology
Mechanism of Action: Muscarinic Antagonism
Datura's psychoactive and toxic effects stem from a single pharmacological mechanism: competitive antagonism at muscarinic acetylcholine receptors (mAChRs). The tropane alkaloids -- atropine, scopolamine, and hyoscyamine -- bind to all five muscarinic receptor subtypes (M1 through M5), but their CNS effects are driven primarily by blockade at M1 and M2 receptors.
Acetylcholine is the primary neurotransmitter of the parasympathetic nervous system and plays critical roles in cortical arousal, attention, memory encoding, and sensory gating. When muscarinic receptors are blocked throughout the brain, the result is a global disruption of cholinergic neurotransmission that produces a characteristic syndrome neurologists call anticholinergic toxidrome. The mnemonic taught in medical schools captures the peripheral effects: "blind as a bat (mydriasis), dry as a bone (anhidrosis), red as a beet (cutaneous vasodilation), mad as a hatter (delirium), hot as a hare (hyperthermia), full as a flask (urinary retention)."
The central delirium is mechanistically distinct from serotonergic psychedelia. Classical psychedelics like LSD and psilocybin work by adding signal -- flooding cortical circuits with novel information via 5-HT2A activation. Anticholinergics work by removing signal -- stripping away the cholinergic scaffolding that maintains coherent perception, working memory, and the ability to distinguish internal mental events from external reality. The result is not expanded consciousness but fragmented consciousness: the brain generates hallucinations and the prefrontal systems that would normally tag them as "not real" are offline.
The Tropane Alkaloids
Scopolamine (hyoscine) is the most CNS-active of the three, crossing the blood-brain barrier more readily than atropine. It is the primary driver of the hallucinatory delirium and amnesia. At therapeutic doses (0.3-0.6 mg), it prevents motion sickness. At the doses present in datura intoxication (estimated 2-15+ mg absorbed), it produces hours to days of florid psychosis.
Atropine (racemic hyoscyamine) has stronger peripheral effects -- tachycardia, mydriasis, bronchodilation -- and contributes to the cardiovascular toxicity that makes datura medically dangerous. It is used clinically as an antidote for organophosphate poisoning and as a pre-anesthetic agent.
Hyoscyamine is the levorotatory enantiomer of atropine and roughly twice as pharmacologically active. It racemizes to atropine during extraction and drying, so the ratio of hyoscyamine to atropine in any given preparation is unpredictable.
The Dosing Problem
This is the central pharmacological fact about datura: you cannot dose it. Alkaloid content in Datura stramonium ranges from 0.2% to 0.6% of dry weight, but this average conceals enormous variation. A 2003 analysis of seeds from the same geographic population found scopolamine content varying by more than 500% between individual plants. Root, leaf, flower, and seed each contain different alkaloid ratios. Young leaves differ from old leaves. Plants grown in drought stress concentrate alkaloids. There is no reliable way to standardize a dose from raw plant material, which is why every harm reduction resource on Earth says the same thing: there is no safe way to use datura recreationally.
Pharmacokinetics
Onset after oral ingestion of seeds typically occurs within 30-60 minutes, though full effects may not manifest for 2-4 hours -- a delay that has led many users to redose with catastrophic results. Peak effects last 6-18 hours, but the total duration of anticholinergic effects frequently extends to 24-72 hours, and residual cognitive impairment (particularly memory deficits) can persist for days. Scopolamine has a half-life of approximately 4-6 hours, but the duration of receptor occupancy exceeds what plasma levels would suggest. Hepatic metabolism is extensive, and renal excretion accounts for less than 10% of elimination.
Detection Methods
Standard Drug Panel Inclusion
Datura is not included on standard 5-panel, 10-panel, or 12-panel immunoassay drug screens. The active tropane alkaloids (atropine, scopolamine, hyoscyamine) can be identified by clinical toxicology laboratories. Clinical presentation (anticholinergic toxidrome) often guides diagnosis rather than laboratory testing. There is no dedicated immunoassay channel for this substance on any commercially available rapid drug test.
Urine Detection
Detection of Datura or its active constituents in urine depends on the specific compound involved. In clinical settings, serum and urine toxicology may be performed using LC-MS/MS or GC-MS to identify the active compounds and their metabolites. Standard urine drug screens will not detect this substance. Detection windows vary from 1 to 4 days depending on the dose, metabolic pathway, and individual physiology.
Blood and Saliva Detection
Blood testing can detect the active compounds from Datura for approximately 12 to 48 hours depending on the half-life of the specific active constituents. Clinical toxicology laboratories can measure serum concentrations when poisoning or overdose is suspected. Saliva testing is not routinely used for this substance.
Hair Follicle Detection
Hair follicle testing for Datura is not available through standard commercial laboratories. Research-grade LC-MS/MS methods could theoretically detect incorporation of active compounds into hair, but this is not a practical detection concern for this substance.
Confirmatory Testing
GC-MS and LC-MS/MS can identify the active compounds associated with Datura in biological specimens. These methods are typically deployed in clinical toxicology, emergency medicine, and forensic contexts rather than routine drug screening. Confirmatory testing can distinguish between different compounds in the same pharmacological class.
Reagent Testing
Reagent testing has limited applicability for Datura. Standard reagent kits (Marquis, Mecke, Mandelin) are designed for purified powder or crystal substances and may not provide useful information for plant-derived preparations or pharmaceutical formulations. Identification of Datura in unknown samples is best accomplished through instrumental analysis.
Interactions
| Substance | Status | Note |
|---|---|---|
| 1,4-Butanediol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| 2-Aminoindane | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2-FA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2-FEA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2-FMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2,5-DMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2C-H | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 2M2B | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| 3-FA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 3-FEA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 3-FMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 3-FPM | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 3-MMC | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 3,4-CTMP | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4-FA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4-FMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4-MMC | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4F-EPH | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 4F-MPH | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 5-APB | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 6-APDB | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| 8-Chlorotheophylline | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| A-PHP | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| A-PVP | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Acetylfentanyl | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Adrafinil | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Alcohol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Alprazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Amphetamine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Armodafinil | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Atropa belladonna | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Baclofen | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Benzodiazepines | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Benzydamine | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Bromantane | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Buprenorphine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Butylone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Caffeine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Cake | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Carisoprodol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Clonazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Clonazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Clonidine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Cocaine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Codeine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Cyclazodone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Deschloroetizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Desomorphine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Desoxypipradrol | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Dextroamphetamine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Dextropropoxyphene | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Diazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Dichloropane | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diclazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Dihydrocodeine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Diphenhydramine | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| Ephedrine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Ephylone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Eszopiclone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| ETH-CAT | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Ethylmorphine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Ethylone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Ethylphenidate | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Etizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| F-Phenibut | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Fenethylline | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Fentanyl | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flualprazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flubromazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flubromazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flunitrazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Flunitrazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Gabapentin | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Gaboxadol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| GBL | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| GHB | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Grayanotoxin | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Heroin | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Hexedrone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Hydrocodone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Hydromorphone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Isopropylphenidate | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Kratom | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Lisdexamfetamine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Lorazepam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| MCPP | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| MDA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| MDMA | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| MDPV | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Mephenaqualone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Methadone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Methamphetamine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Methaqualone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Methcathinone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Methiopropamine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Methylnaphthidate | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Methylone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Methylphenidate | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Metizolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Mexedrone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Midazolam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Mirtazapine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Modafinil | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Morphine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Myristicin | Dangerous | Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure |
| N-Ethylhexedrone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| N-Methylbisfluoromodafinil | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Naloxone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| NEP | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Nicotine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Nifoxipam | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| NM-2-AI | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| O-Desmethyltramadol | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Oxiracetam | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Oxycodone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Oxymorphone | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Pentedrone | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Pentobarbital | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Pethidine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Phenobarbital | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Phenylpiracetam | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Rhodiola Rosea | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| SAMe | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| 1,3-Butanediol | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 1B-LSD | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 1cP-AL-LAD | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 1cP-LSD | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
| 1cP-MiPLA | Caution | Unpredictable compounding of hallucinogenic effects with anticholinergic delirium |
History
Ancient and Sacred Use
Datura species have been used by humans for millennia across nearly every continent where they grow, making them among the oldest psychoactive plants in continuous human use. The relationship is ancient, global, and invariably surrounded by fear and reverence in equal measure.
In the Indian subcontinent, datura holds a position of genuine religious significance. It is sacred to Shiva, the destroyer and transformer, and Datura metel flowers and seeds are offered at Shiva temples across India to this day. The Atharvaveda, composed roughly 3,000 years ago, references datura-like preparations. Ayurvedic medicine has used carefully prepared datura formulations for asthma, pain, and inflammation for centuries -- always with explicit warnings about its toxicity and always under the supervision of experienced practitioners who understood that the margin between medicine and poison was vanishingly thin.
In the Americas, multiple Indigenous traditions used Datura wrightii and related species in coming-of-age ceremonies and shamanic practice. The Chumash of California used momoy (Datura wrightii) in adolescent initiation rites under the guidance of elders -- a practice that sometimes resulted in death, which was understood as an inherent risk of the ritual. The Aztecs called it toloatzin and used it medicinally and ceremonially, but with clear cultural restrictions on who could use it and when.
The Jamestown Incident
The most famous datura poisoning in Western history occurred in 1676 in Jamestown, Virginia. British soldiers sent to suppress Bacon's Rebellion boiled the young leaves of Datura stramonium and ate them as salad. Robert Beverly's 1705 History and Present State of Virginia describes the aftermath: the soldiers spent eleven days in a state of florid delirium, "turning several objects from one thing to another," blowing feathers, making faces, and sitting naked in corners grinning. Some kissed and embraced their companions. Others stared like dead men. Upon recovering, "they had no memory of anything that had happened." The plant became permanently known as "Jimsonweed" -- a contraction of "Jamestown Weed."
European Witchcraft and Flying Ointments
The tropane alkaloid-containing plants of Europe -- datura, henbane (Hyoscyamus niger), mandrake (Mandragora officinarum), and deadly nightshade (Atropa belladonna) -- feature prominently in witch trial records and medieval pharmacology. "Flying ointments," applied to mucous membranes, reportedly contained these plants and produced vivid sensations of flight and shapeshifting. Modern analysis suggests the combination of scopolamine's hallucinogenic effects with transdermal absorption through vaginal or rectal mucous membranes (using a staff or broomstick as an applicator -- possibly the origin of the "witch on a broomstick" image) could plausibly produce these experiences. The name "belladonna" itself comes from Italian women using atropine eye drops to dilate their pupils for cosmetic effect.
Modern Poisonings and Forensic Significance
Datura has a long and grim history as a poison. In India, datura poisoning has been used for robbery and murder for centuries -- the Thuggee were reported to have used it to incapacitate victims. A retrospective analysis of poisoning cases in Agra, India between 1950 and 1965 documented 2,778 datura poisoning cases, the vast majority criminal. Scopolamine-based robbery ("Devil's Breath") remains an active concern in parts of South America, where powdered scopolamine is reportedly blown into victims' faces or slipped into drinks to induce compliance and amnesia.
In the modern era, datura poisoning primarily affects adolescents and young adults who consume seeds recreationally after encountering reports online. Emergency department presentations are a regular occurrence worldwide. Deaths, while less common than hospitalizations, occur every year -- from hyperthermia, cardiac arrhythmia, trauma sustained during delirium, drowning, or aspiration. The precise mortality rate is unknown because many cases are likely unreported or misdiagnosed, but case reports and poison control data confirm that datura kills people with grim regularity.
Harm Reduction
The Only Safe Dose Is None
This is not a rhetorical device. The 5:1 or greater variation in alkaloid content between individual plants means that no preparation method produces a reliable dose. Seeds from the same pod can vary dramatically. A "dose" that one person survived comfortably has killed the next person who tried the same quantity from a different plant. Every harm reduction organization that addresses datura -- DanceSafe, The Loop, Erowid, PsychonautWiki -- arrives at the same conclusion: there is no way to use this substance with acceptable risk.
If someone has already decided to use datura despite this, the following may reduce (but cannot eliminate) the risk of serious harm or death.
If Use Cannot Be Prevented
- Never use alone -- this is absolute. Datura produces delirium in which you will not know you are intoxicated, cannot make rational decisions, and may wander into traffic, fall from heights, or drown. A sober sitter who physically restrains you from leaving is not excessive -- it is the minimum
- Start with the absolute smallest amount possible -- a single seed, a tiny piece of leaf. Wait at least 4-6 hours before considering any redose. The onset is slow and deceptive
- Remove all car keys, weapons, medications, and access to water hazards before onset. Delirious people drown in bathtubs, walk into pools, and attempt to drive
- Do not combine with any other substance -- alcohol, opioids, and other anticholinergics (diphenhydramine, etc.) compound CNS depression and cardiac toxicity
- Have someone monitor body temperature -- hyperthermia is the most medically dangerous acute effect and requires active cooling (cold water, ice packs, air conditioning)
- Monitor heart rate -- sustained tachycardia above 150 bpm or any irregular rhythm warrants emergency medical attention
- Write down what you took, how much, and when -- give this information to your sitter. If medical attention is needed, paramedics need to know it was an anticholinergic plant
Recognizing Anticholinergic Toxidrome
The following constellation of symptoms means tropane alkaloid poisoning is occurring:
- Dilated pupils that do not respond to light
- Dry mouth, dry skin, no sweating
- Flushed, hot skin
- Rapid heart rate
- Urinary retention
- Agitation or delirium
- Hallucinations the person believes are real
If these symptoms are severe, particularly if body temperature is rising or the person is seizing, this is a medical emergency. Call 911 immediately.
In the Emergency Department
Tell medical staff it was datura or a tropane alkaloid plant. The word "anticholinergic" will immediately orient their treatment. Physostigmine -- a cholinesterase inhibitor that crosses the blood-brain barrier -- can reverse the central delirium, though its use requires monitoring for cholinergic crisis. Benzodiazepines may be given for severe agitation. Active cooling for hyperthermia. IV fluids. Cardiac monitoring.
For People Who Have Already Used Datura
If you survived a datura experience and are struggling with the aftermath -- persistent anxiety, derealization, cognitive fog, or trauma from the experience -- these are normal responses to anticholinergic poisoning. The cognitive effects typically resolve within days to weeks. Seek support from a therapist familiar with substance-related trauma, or from online communities like r/Datura and Erowid's experience vault. You are not permanently damaged. The brain recovers from anticholinergic insult, though it takes time.
Toxicity & Safety
Acute Toxicity: The Anticholinergic Crisis
Datura is genuinely toxic in a way that most psychoactive substances are not. The tropane alkaloids produce dose-dependent anticholinergic poisoning with effects on nearly every organ system, and the "dose" is inherently unknowable from raw plant material. This is not theoretical risk management -- this is a plant that sends people to intensive care units and morgues.
Cardiovascular toxicity is the most immediately life-threatening effect. Atropine produces sinus tachycardia that can exceed 150-180 bpm, and at toxic doses can trigger supraventricular tachycardia, ventricular tachycardia, and fatal arrhythmias. The combination of tachycardia, impaired thermoregulation, and agitation creates compounding cardiovascular stress.
Hyperthermia results from the simultaneous loss of sweating (anhidrosis from sweat gland muscarinic blockade) and increased metabolic heat production from agitation and muscle activity. Core body temperature can reach 40-42 degrees C (104-108 degrees F). Sustained hyperthermia causes rhabdomyolysis, organ failure, and death. This is the mechanism by which datura most commonly kills.
Respiratory compromise can result from aspiration of vomitus during delirium, bronchospasm in susceptible individuals, or central respiratory depression at extreme doses.
Seizures occur in severe poisoning, particularly in children, who are more susceptible to anticholinergic toxicity relative to body weight.
The Dosing Uncertainty
The lethal dose of atropine in adults is estimated at approximately 10 mg, and for scopolamine roughly 2-4 mg -- but these numbers are averages across populations, and individual sensitivity varies considerably. A single Datura stramonium seed pod can contain 50-100 seeds, with total alkaloid content per pod ranging from less than 1 mg to over 15 mg depending on the plant. Some trip reports describe consuming 50-100 seeds and surviving with severe intoxication; others describe fatalities from similar or smaller quantities. This unpredictability is not a bug in datura use -- it is the fundamental, inescapable feature.
Chronic Effects
Repeated datura use -- uncommon, given the nature of the experience, but documented -- is associated with persistent cognitive impairment, particularly in memory and attention. The cholinergic system is central to memory encoding, and sustained anticholinergic assault on this system mirrors, in accelerated form, the cholinergic deficits seen in Alzheimer's disease. Whether these effects are fully reversible with cessation is not well-established, because longitudinal studies of recreational datura users essentially do not exist.
Populations at Extreme Risk
Children and adolescents are disproportionately represented in fatal datura poisonings due to lower body weight and higher relative alkaloid exposure. Individuals taking other anticholinergic medications (diphenhydramine, tricyclic antidepressants, certain antipsychotics) face compounding toxicity. People with cardiac conditions, particularly arrhythmias, face elevated risk of fatal cardiac events. Elderly individuals are more sensitive to anticholinergic CNS effects.
Addiction Potential
Datura has essentially no addiction potential in the conventional sense. It does not produce euphoria, does not activate reward circuitry in any meaningful way, does not cause physical dependence, and does not produce cravings or compulsive redosing. The experience is so overwhelmingly unpleasant that the vast majority of people who try it once never voluntarily use it again -- a pattern so consistent that it constitutes perhaps the strongest natural deterrent of any psychoactive substance. That said, there are rare documented cases of habitual datura use, particularly in parts of South Asia where traditional preparations are culturally embedded, and in a small subset of individuals who develop what appears to be a compulsive relationship with the deliriant state itself. These cases are uncommon enough to be the subject of individual case reports rather than epidemiological study. The pharmacological basis for any such pattern is unclear, though chronic anticholinergic use does produce tolerance, requiring escalating doses to achieve the same degree of delirium -- a pattern that dramatically increases the risk of fatal poisoning. The real danger with datura is not addiction but single-use catastrophe. One experience can result in death, permanent injury from trauma sustained during delirium, legal consequences from behavior during a psychotic state, or lasting psychological trauma. The risk profile is front-loaded onto the first and only use in a way that makes addiction potential almost irrelevant to the harm calculus.
Overdose Information
Datura Overdose Is a Medical Emergency
Unlike most psychoactive substances covered on this site, there is no meaningful distinction between "a datura experience" and "datura poisoning." Every recreational use of datura is, pharmacologically speaking, a case of anticholinergic poisoning of varying severity. The question is not whether you have been poisoned, but how badly.
Signs of Severe Anticholinergic Poisoning
Seek emergency medical attention immediately for any of the following:
- Body temperature above 39 degrees C (102 degrees F) -- hyperthermia is the primary killer and requires immediate active cooling
- Heart rate above 150 bpm or any irregular rhythm -- cardiac arrhythmias can be fatal
- Seizures -- more common in children and with higher doses
- Inability to urinate (urinary retention) -- painful and potentially dangerous if prolonged
- Complete unresponsiveness or loss of consciousness
- Violent agitation that poses danger to the person or others
- Signs of rhabdomyolysis -- dark brown urine, severe muscle pain, muscle rigidity
What To Do
Call 911 immediately. Tell them it was datura, jimsonweed, or an anticholinergic plant poisoning. This single piece of information will immediately orient emergency treatment.
While waiting for paramedics:
- Cool the person -- remove excess clothing, apply cold water or ice packs to neck, armpits, and groin, move to air conditioning. Hyperthermia kills and every minute counts
- Place in recovery position if consciousness is impaired, to prevent aspiration of vomit
- Do not attempt to induce vomiting -- the person may aspirate
- Do not give activated charcoal unless directed by poison control or EMS -- aspiration risk is too high in a delirious patient
- Do not restrain violently -- agitated patients can develop fatal excited delirium. Use the minimum restraint necessary for safety
- Remove environmental hazards -- the person is delirious and cannot assess danger. Remove access to heights, water, roads, sharp objects, and vehicles
Hospital Treatment
Physostigmine is the specific antidote for anticholinergic poisoning. It is a cholinesterase inhibitor that crosses the blood-brain barrier, reversing both peripheral and central anticholinergic effects. It must be administered slowly IV with cardiac monitoring, as rapid administration or use in patients with cardiac conduction abnormalities can cause bradycardia or asystole. Not all emergency physicians are comfortable using it, but current toxicology guidance supports its use in pure anticholinergic poisoning with severe agitation or delirium.
Supportive care includes IV fluid resuscitation, active cooling for hyperthermia, benzodiazepines for seizures and agitation, continuous cardiac monitoring, and bladder catheterization for urinary retention. ICU admission is common for severe cases. The prolonged duration of tropane alkaloid effects (24-72+ hours) means patients may require extended observation.
After Discharge
Residual cognitive effects -- particularly memory impairment, difficulty concentrating, and blurred vision -- may persist for days to weeks. This is normal recovery from anticholinergic insult and typically resolves completely. If visual disturbances (mydriasis) persist beyond a week, see an ophthalmologist.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure
Tolerance
| Full | with repeated use |
| Half | 3 - 7 days |
| Zero | 1 - 2 weeks |
Cross-tolerances
Legal Status
Datura grows naturally and is legal to grow, sell and consume in most parts of the world. It is, however, restricted within the following countries:
Australia:** Datura is a Schedule I poison in Australia, but scopolamine is Schedule 4 (Prescription only) and a scopolamine analogue (hyoscine butylbromide) is available in over the counter drugs (e.g. Buscopan & others) to treat symptoms such as nausea, stomach pain and cramps. Datura and Brugsmansia are legal to process, but are illegal to cultivate without a license.
Brazil:** Datura (suaveolens Willd.) is illegal to grow, handle, possess, store, transport, import, export, prescribe, administer, sell and advertise.
United Kingdom:** Datura is illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.
United States: Datura is legal to produce, supply and import.
California: Except for legitimate medical purposes, a person may not possess or use the plant known as Datura stramonium
Responsible use
Tropane alkaloids
Datura (Wikipedia)
Datura* (Erowid)
Scopolamine (DrugBank)
Atropine (DrugBank)
Hyoscyamine (DrugBank)
Datura (Drugs-Wiki)
Discussion
The Big & Dandy Datura Thread (Bluelight)
Experience Reports (2)
Tips (10)
Datura is one of the most dangerous commonly discussed psychoactive plants. Unlike psychedelics, the hallucinations are indistinguishable from reality — you will not know you are hallucinating. Users routinely interact with people who aren't there, wander into traffic, or injure themselves. There is no safe recreational dose.
If you insist on using Datura, NEVER do so alone. You will not be able to distinguish hallucination from reality and may walk into traffic, consume dangerous objects, or injure yourself. A sober sitter is absolutely essential.
Datura poisoning can last 24-72 hours and may require hospitalization. Effects include dangerous hyperthermia, tachycardia, urinary retention, seizures, and complete delirium. If someone has ingested Datura and is exhibiting confusion, hot dry skin, dilated pupils, and rapid heartbeat, call emergency services immediately.
Datura's alkaloid content (scopolamine, atropine, hyoscyamine) varies dramatically between individual plants, plant parts, and even seeds from the same pod. This makes consistent dosing essentially impossible. What was a moderate dose from one seed pod could be lethal from another.
Datura is one of the most dangerous deliriants available. Potency varies enormously between plants, between parts of the same plant, and even between seeds. There is NO way to estimate a safe dose from raw plant material.
If you are absolutely determined to use Datura (which is strongly discouraged), you need an experienced, sober sitter who is prepared to physically restrain you and call 911. Users under Datura's influence frequently try to leave the house, drive cars, or perform dangerous activities while fully convinced they are doing something mundane.
Community Discussions (4)
See Also
References (2)
- Datura - TripSit Factsheet
TripSit factsheet for Datura
tripsit - Datura - Wikipedia
Wikipedia article on Datura
wikipedia